{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:58:42Z","timestamp":1793293122968,"version":"4.5.0"},"reference-count":27,"publisher":"Scientific Scholar","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008212","name":"College of Medicine, Drexel University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008212","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Orthopaedics"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jor.2025.08.016","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T16:02:23Z","timestamp":1754582543000},"page":"235-240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Glucagon-like Peptide-1 receptor agonist use is not associated with increased reoperation risk following rotator cuff repair"],"prefix":"10.25259","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-3481-0808","authenticated-orcid":false,"given":"Spencer T.","family":"Rasmussen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5636-9873","authenticated-orcid":false,"given":"Asif M.","family":"Ilyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"10.1016\/j.jor.2025.08.016_bib1","article-title":"National diabetes statistics report","year":"2024","journal-title":"Diabetes"},{"key":"10.1016\/j.jor.2025.08.016_bib2","series-title":"Obesity and Severe Obesity Prevalence in Adults: United States, August 2021\u2013August 2023","author":"Emmerich","year":"2024"},{"issue":"4","key":"10.1016\/j.jor.2025.08.016_bib3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41569-020-00465-5","article-title":"Diabesity: the combined burden of obesity and diabetes on heart disease and the role of imaging","volume":"18","author":"Ng","year":"2021","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"10.1016\/j.jor.2025.08.016_bib4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/sj.ijo.0803715","article-title":"The impact of obesity on the musculoskeletal system","volume":"32","author":"Anandacoomarasamy","year":"2008","journal-title":"Int J Obes"},{"issue":"1","key":"10.1016\/j.jor.2025.08.016_bib5","first-page":"43","article-title":"The musculoskeletal effects of diabetes mellitus","volume":"50","author":"Wyatt","year":"2006","journal-title":"J Can Chiropr Assoc"},{"issue":"1","key":"10.1016\/j.jor.2025.08.016_bib6","doi-asserted-by":"crossref","DOI":"10.1097\/j.pbj.0000000000000112","article-title":"Diabetes: a silent player in musculoskeletal interventional radiology response","volume":"6","author":"Dimitri-Pinheiro","year":"2021","journal-title":"Porto Biomed J"},{"key":"10.1016\/j.jor.2025.08.016_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1320468","article-title":"The association between diabetes mellitus and musculoskeletal disorders: a systematic review and meta-analysis","volume":"15","author":"Azami","year":"2024","journal-title":"Front Endocrinol"},{"issue":"6","key":"10.1016\/j.jor.2025.08.016_bib8","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.3904\/kjim.2022.168","article-title":"Musculoskeletal complications in patients with diabetes mellitus","volume":"37","author":"Choi","year":"2022","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.jor.2025.08.016_bib9","doi-asserted-by":"crossref","DOI":"10.7573\/dic.212283","article-title":"A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyond","volume":"4","author":"Prasad-Reddy","year":"2015","journal-title":"Drugs Context"},{"key":"10.1016\/j.jor.2025.08.016_bib10","article-title":"Mechanisms of action and therapeutic applications of GLP-1 and dual GIP\/GLP-1 receptor agonists","volume":"15","author":"Liu","year":"2024","journal-title":"Front Endocrinol"},{"issue":"3","key":"10.1016\/j.jor.2025.08.016_bib11","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s12325-022-02394-w","article-title":"GLP-1 agonists for weight loss: pharmacology and clinical implications","volume":"40","author":"Moore","year":"2023","journal-title":"Adv Ther"},{"issue":"11","key":"10.1016\/j.jor.2025.08.016_bib12","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1016\/j.arth.2023.05.071","article-title":"Does semaglutide use decrease complications and costs following total knee arthroplasty?","volume":"38","author":"Magruder","year":"2023","journal-title":"J Arthroplast"},{"issue":"3","key":"10.1016\/j.jor.2025.08.016_bib13","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.arth.2023.12.023","article-title":"Semaglutide use prior to total hip arthroplasty results in fewer postoperative prosthetic joint infections and readmissions","volume":"39","author":"Magruder","year":"2024","journal-title":"J Arthroplast"},{"issue":"5","key":"10.1016\/j.jor.2025.08.016_bib14","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.jse.2024.09.012","article-title":"Glucagon-like peptide-1 receptor agonist use is associated with increased risk of perioperative complication and readmission following shoulder arthroplasty","volume":"34","author":"Lawand","year":"2025","journal-title":"J Shoulder Elb Surg"},{"issue":"2","key":"10.1016\/j.jor.2025.08.016_bib15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.arthro.2024.09.057","article-title":"Lower risk of postoperative complications and rotator cuff retear associated with semaglutide use in patients with type II diabetes mellitus undergoing arthroscopic rotator cuff repair","volume":"41","author":"Seddio","year":"2025","journal-title":"Arthrosc J Arthrosc Relat Surg"},{"key":"10.1016\/j.jor.2025.08.016_bib16","series-title":"StatPearls","article-title":"Glucagon-like Peptide-1 receptor agonists","author":"Collins","year":"2025"},{"issue":"2","key":"10.1016\/j.jor.2025.08.016_bib17","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/CRD.0000000000000351","article-title":"Semaglutide: a novel oral glucagon-like peptide receptor agonist for the treatment of type 2 diabetes mellitus","volume":"29","author":"Chan","year":"2021","journal-title":"Cardiol Rev"},{"issue":"5","key":"10.1016\/j.jor.2025.08.016_bib18","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s40262-015-0338-3","article-title":"Clinical pharmacokinetics of dulaglutide in patients with type 2 diabetes: analyses of data from clinical trials","volume":"55","author":"Geiser","year":"2016","journal-title":"Clin Pharmacokinet"},{"issue":"12","key":"10.1016\/j.jor.2025.08.016_bib19","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1177\/0091270011430504","article-title":"Dosing rationale for liraglutide in type 2 diabetes mellitus: a pharmacometric assessment","volume":"52","author":"Ingwersen","year":"2012","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jor.2025.08.016_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106320","article-title":"The anti-inflammatory and immunological properties of GLP-1 receptor agonists","volume":"182","author":"Bendotti","year":"2022","journal-title":"Pharmacol Res"},{"issue":"6","key":"10.1016\/j.jor.2025.08.016_bib21","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.cmet.2024.05.001","article-title":"Glucagon-like peptide 1 receptor is a T cell-negative costimulatory molecule","volume":"36","author":"Nasr","year":"2024","journal-title":"Cell Metab"},{"key":"10.1016\/j.jor.2025.08.016_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1148209","article-title":"Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent","volume":"14","author":"Mehdi","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.jor.2025.08.016_bib23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.32098\/mltj.01.2016.04","article-title":"Adhesive capsulitis of the shoulder and diabetes: a meta-analysis of prevalence","volume":"6","author":"Zreik","year":"2016","journal-title":"Muscles Ligaments Tendons J"},{"key":"10.1016\/j.jor.2025.08.016_bib24","article-title":"GLP-1 agonist use increases the incidence of adhesive capsulitis and odds of requiring operative management in type 2 diabetes patients: a matched propensity score analysis","volume":"22","author":"Bergstein","year":"2025","journal-title":"J Shoulder Elb Surg"},{"issue":"1","key":"10.1016\/j.jor.2025.08.016_bib25","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1186\/s12891-021-04634-6","article-title":"Retear rates after rotator cuff surgery: a systematic review and meta-analysis","volume":"22","author":"Longo","year":"2021","journal-title":"BMC Musculoskelet Disord"},{"issue":"8","key":"10.1016\/j.jor.2025.08.016_bib26","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.28280","article-title":"Safety and risk assessment of No-Prescription online semaglutide purchases","volume":"7","author":"Ashraf","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jor.2025.08.016_bib27","unstructured":"Publication guidelines. TriNetX. Accessed July 3, 2025. https:\/\/trinetx.com\/real-world-resources\/case-studies-publications\/trinetx-publication-guidelines\/."}],"container-title":["Journal of Orthopaedics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0972978X25003186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0972978X25003186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T14:09:33Z","timestamp":1789135773000},"score":1,"resource":{"primary":{"URL":"https:\/\/jortho.org\/glucagon-like-peptide-1-receptor-agonist-use-is-not-associated-with-increased-reoperation-risk-following-rotator-cuff-repair\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":27,"alternative-id":["S0972978X25003186"],"URL":"https:\/\/doi.org\/10.1016\/j.jor.2025.08.016","relation":{},"ISSN":["0972-978X"],"issn-type":[{"value":"0972-978X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucagon-like Peptide-1 receptor agonist use is not associated with increased reoperation risk following rotator cuff repair","name":"articletitle","label":"Article Title"},{"value":"Journal of Orthopaedics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jor.2025.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V. on behalf of Professor P K Surendran Memorial Education Foundation.","name":"copyright","label":"Copyright"}]}}